Capital Flow Monitor · Sponsors · CIK 2141473
Vivo Drakkar Co-Invest Fund, L.P.
1 KIM SENG PROMENADE, SINGAPORE, U0, 237994 · (65) 6019 0762
Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. CAYMAN ISLANDS true 2026
Fit score
—
Offering
—
Sold
$0
% sold
—
Investors
0
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | D ·current | 506(b) | — | $0 | — | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- n/a Vivo Drakkar GP, LLC — Promoter, Singapore, U0
-
Frank Kung — Executive Officer, Palo Alto, CA
4 other raises
- Vivo Opportunity Fund, L.P. $816.9M of —
- Vivo Opportunity Co-Invest (Cycle 3), L.P. $0 of —
- Vivo Capital Fund X, L.P. $717.0M of —
- Vivo Opportunity Cayman Fund, L.P. $148.5M of —
-
Shan Fu — Executive Officer, Chaoyang District, Beijing, F4
4 other raises
- Vivo Opportunity Fund, L.P. $816.9M of —
- Vivo Opportunity Co-Invest (Cycle 3), L.P. $0 of —
- Vivo Capital Fund X, L.P. $717.0M of —
- Vivo Opportunity Cayman Fund, L.P. $148.5M of —
-
Edgar Engleman — Executive Officer, Palo Alto, CA
1 other raise
- Vivo Capital Fund X, L.P. $717.0M of —
-
Michael Chang — Executive Officer, Singapore, U0
3 other raises
- AEMS Corp. $100K of $700K · 14.3%
- SWNB BANCORP INC $30.0M of $30.0M · 100.0%
- Vivo Capital Fund X, L.P. $717.0M of —
-
David Liu — Executive Officer, Chaoyang District, Beijing, F4
2 other raises
- Edesa Biotech, Inc. $3.5M of $3.5M · 100.0%
- Vivo Capital Fund X, L.P. $717.0M of —
-
Gaurav Aggarwal — Executive Officer, Palo Alto, CA
5 other raises
- Vivo Opportunity Fund, L.P. $816.9M of —
- Bonum Therapeutics, Inc. $26.9M of $32.3M · 83.3%
- Vivo Opportunity Co-Invest (Cycle 3), L.P. $0 of —
- Vivo Capital Fund X, L.P. $717.0M of —
- Vivo Opportunity Cayman Fund, L.P. $148.5M of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.